Literature DB >> 20192060

Impact of the Japanese diagnosis procedure combination-based payment system in Japan.

Kai Wang1, Ping Li, Ling Chen, Ken Kato, Makoto Kobayashi, Kazunobu Yamauchi.   

Abstract

In the health insurance system of Japan, a fee-for-service system has been applied to individual treatment services since 1958. This system involves a structural problem of causing an increase in examination and drug administration. A flat-fee payment system called DPC was introduced in April 2003 to solve the problems of the fee-for-service system. Based on the data of 2003 and 2004, we assessed the impact of DPC in Japan, and obtained the following conclusions: First, the introduction of DPC in Japan could not decrease the absolute value of medical costs; second, the internal efficiency of the institutions was improved, for example, by reducing the mean length of hospitalizations; third, the DPC-based diagnosis classification is considered to be effective for simplifying the medical fee system within the framework of EBM and for providing patients with information; and fourth, after introduction of the DPC, structural problems remain in the flat-fee payment system, such as examination and treatment of low quality, selection of patients and up coding. Its introduction should thus be performed with sufficient caution. We will make greater efforts to establish a better medical fee system by evaluating these problems.

Entities:  

Mesh:

Year:  2010        PMID: 20192060     DOI: 10.1007/s10916-008-9220-2

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  25 in total

1.  Study of the cost-benefit analysis of electronic medical record systems in general hospital in China.

Authors:  Kai Li; Shinji Naganawa; Kai Wang; Ping Li; Ken Kato; Xiu Li; Jie Zhang; Kazunobu Yamauchi
Journal:  J Med Syst       Date:  2012-01-03       Impact factor: 4.460

2.  Effect on Completion of Clinical Pathway for Improving Clinical Indicator: Cases of Hospital Stay, Mortality Rate, and Comprehensive-Volume Ratio.

Authors:  Hiroki Furuhata; Kenji Araki; Taisuke Ogawa; Mitsuru Ikeda
Journal:  J Med Syst       Date:  2017-11-13       Impact factor: 4.460

3.  Impact of hospital length of stay on the risk of readmission and overall survival after allogeneic stem cell transplantation.

Authors:  Aika Seto; Yoshiko Atsuta; Naomi Kawashima; Yukiyasu Ozawa; Koichi Miyamura; Hitoshi Kiyoi
Journal:  Int J Hematol       Date:  2018-06-19       Impact factor: 2.490

4.  Influence of hospital surgical volume of radical prostatectomy on quality of perioperative care.

Authors:  Yoshikatsu Nojiri; Kikuo Okamura; Yoshinori Tanaka; Hitoshi Yanaihara; Naoto Sassa; Ryohei Hattori; Jiroh Machida; Katsuyoshi Hashine; Tadashi Matsuda; Yoichi Arai; Seiji Naito; Tomonori Hasegawa
Journal:  Int J Clin Oncol       Date:  2012-08-11       Impact factor: 3.402

5.  Changes in compliance with Japanese antiemetic guideline for chemotherapy-induced nausea and vomiting: a nationwide survey using a distributed research network.

Authors:  Katsuhito Hori; Norihiro Kobayashi; Hitoshi Atsumi; Akira Nagayama; Masako Kondoh; Ichiro Noge; Midori Kimura; Hiroaki Utsugi; Tsuyoshi Iwasaki; Masaki Nakamura; Tomomi Kimura
Journal:  Support Care Cancer       Date:  2013-11-26       Impact factor: 3.603

6.  Cost of illness of the stomach cancer in Japan - a time trend and future projections.

Authors:  Kayoko Haga; Kunichika Matsumoto; Takefumi Kitazawa; Kanako Seto; Shigeru Fujita; Tomonori Hasegawa
Journal:  BMC Health Serv Res       Date:  2013-07-23       Impact factor: 2.655

7.  Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib.

Authors:  Jörg Mahlich; Shinichiro Okamoto; Akiko Tsubota
Journal:  Pharmacoecon Open       Date:  2017-09

8.  Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis.

Authors:  Stephane Cheung; Yukinobu Hamuro; Jörg Mahlich; Takanobu Nakahara; Rosarin Sruamsiri; Sunny Tsukazawa
Journal:  Clin Drug Investig       Date:  2017-06       Impact factor: 2.859

9.  Expansion of discharge planning system in Japan: Comparison of results of a nationwide survey between 2001 and 2010.

Authors:  Satoko Nagata; Hikari Tomura; Sachiyo Murashima
Journal:  BMC Health Serv Res       Date:  2012-08-03       Impact factor: 2.655

10.  Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan.

Authors:  Jörg Mahlich; Rosarin Sruamsiri
Journal:  Patient Prefer Adherence       Date:  2016-08-05       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.